IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4775-4782

  Yang, Dafeng ^a   Thangaraju, Muthusamy ^a   Browning, Darren D ^a   Dong, Zheng ^a   Korchin, Borys ^b   Lev, Dina C ^b   Ganapathy, Vadivel ^a   Liu, Kebin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; JANUS KINASE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON REGULATORY FACTORS; INTERFERON-GAMMA; MICE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SARCOMA; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51349131172     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4775     Document Type: Article

References (56)

1. Rosenbauer, F., A. Kallies, M. Scheller, K. P. Knobeloch, C. O. Rock, M. Schwieger, C. Stocking, and I. Horak. 2002. Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. EMBO J. 21: 211-220.
2. Zhu, C., K. Rao, H. Xiong, K. Gagnidze, F. Li, C. Horvath, and S. Plevy. 2003. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J. Biol. Chem. 278: 39372-39382.
3. Schmidt, M., J. Bies, T. Tamura, K. Ozato, and L. Wolff. 2004. The interferon regulatory factor ICSBP/IRF8 in combination with PU.1 up-regulates p15INK4b tumor suppressor expression in murine myeloid cells. Blood 103: 4142-4149.
4. Burchert, A., D. Cai, L. C. Hofbauer, M. K. Samuelsson, E. P. Slater, J. Duyster, M. Ritter, A. Hochhaus, R. Muller, M. Eilers, et al. 2004. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103: 3480-3489.
5. Huang, W., E. Horvath, and E. A. Eklund. 2007. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. J. Biol. Chem. 282: 6629-6643.
6. Schroder, K., M. Lichtinger, K. M. Irvine, K. Brion, A. Trieu, I. L. Ross, T. Ravasi, K. J. Stacey, M. Rehli, D. A. Hume, and M. J. Sweet. 2007. PU.1 and ICSBP control constitutive and IFN-γ-regulated Tlr9 gene expression in mouse macrophages. J. Leukocyte Biol. 81: 1577-1590.
7. Dror, N., N. Rave-Harel, A. Burchert, A. Azriel, T. Tamura, P. Tailor, A. Neubauer, K. Ozato, and B. Z. Levi. 2007. Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells. J. Biol. Chem. 282: 5633-5640.
8. Nguyen, H., J. Hiscott, and P. M. Pitha. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8: 293-312.
9. Tamura, T., and K. Ozato. 2002. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22: 145-152.
10. Levi, B. Z., S. Hashmueli, M. Gleit-Kielmanowicz, A. Azriel, and D. Meraro. 2002. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J. Interferon Cytokine Res. 22: 153-160.
11. Meraro, D., M. Gleit-Kielmanowicz, H. Hauser, and B. Z. Levi. 2002. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 168: 6224-6231.
12. Dror, N., N. Rave-Harel, A. Burchert, A. Azriel, T. Tamura, P. Tailor, A. Neubauer, K. Ozato, and B. Z. Levi. 2007. Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells. J. Biol. Chem. 282: 5633-5640.
13. Hanada, T., T. Kobayashi, T. Chinen, K. Saeki, H. Takaki, K. Koga, Y. Minoda, T. Sanada, T. Yoshioka, H. Mimata, et al. 2006. IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J. Exp. Med. 203: 1391-1397.
14. Bunt, S. K., P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg. 2006. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176: 284-290.
15. de Visser, K. E., A. Eichten, and L. M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6: 24-37.
16. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFN-γ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111.
17. Dighe, A. S., E. Richards, L. J. Old, and R. D. Schreiber. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN-γ receptors. Immunity 1: 447-456.
18. Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22: 329-360.
19. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95: 7556-7561.
20. Holtschke, T., J. Lohler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K. P. Knobeloch, L. Gabriele, J. F. Waring, et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-317.
21. Gabriele, L., J. Phung, J. Fukumoto, D. Segal, I. M. Wang, P. Giannakakou, N. A. Giese, K. Ozato, and H. C. Morse. 1999. Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J. Exp. Med. 190: 411-421.
22. Middleton, M. K., A. M. Zukas, T. Rubinstein, M. Jacob, P. Zhu, L. Zhao, I. Blair, and E. Pure. 2006. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J. Exp. Med. 203: 2529-2540.
23. Schmidt, M., S. Nagel, J. Proba, C. Thiede, M. Ritter, J. F. Waring, F. Rosenbauer, D. Huhn, B. Wittig, I. Horak, and A. Neubauer. 1998. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91: 22-29.
24. Xiong, H., C. Zhu, H. Li, F. Chen, L. Mayer, K. Ozato, J. C. Unkeless, and S. E. Plevy. 2003. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-γ-induced iNOS gene expression. J. Biol. Chem. 278: 2271-2277.
25. Liu, K., and S. I. Abrams. 2003. Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-γ. J. Immunol. 170: 6329-6337.
26. Egwuagu, C. E., W. Li, C. R. Yu, M. Che Mei Lin, C. C. Chan, T. Nakamura, and A. B. Chepelinsky. 2006. Interferon-γ induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors. Oncogene 25: 3670-3679.
27. Yang, D., M. Thangaraju, G. Greeneltch, D. D. Browning, S. Schoenlein, T. Tamura, K. Ozato, V. Ganapathy, S. I. Abrams, and K. Liu. 2007. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res. 67: 3301-3309.
28. Liu, K., S. A. Caldwell, and S. I. Abrams. 2005. Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency. Cancer Res. 65: 1045-1054.
29. Liu, K., E. McDuffie, and S. I. Abrams. 2003. Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations. J. Immunol. 171: 4164-4174.
30. Liu, K., and S. I. Abrams. 2003. Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence. J. Immunol. 170: 5973-5980.
31. + memory T cells. Proc. Natl. Acad. Sci. USA 99: 6192-6197.
32. Tamura, T., P. Thotakura, T. S. Tanaka, M. S. Ko, and K. Ozato. 2005. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106: 1938-1947.
33. Laricchia-Robbio, L., T. Tamura, T. Karpova, B. L. Sprague, J. G. McNally, and K. Ozato. 2005. Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc. Natl. Acad. Sci. USA 102: 14368-14373.
34. Cohen, H., A. Azriel, T. Cohen, D. Meraro, S. Hashmueli, D. Bech-Otschir, R. Kraft, W. Dubiel, and B. Z. Levi. 2000. Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15): a possible link between interferon regulatory factor signaling and the COP9/signalosome. J. Biol. Chem. 275: 39081-39089.
35. Kanno, Y., B. Z. Levi, T. Tamura, and K. Ozato. 2005. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine Res. 25: 770-779.
36. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
37. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591.
38. Greenlund, A. C., M. A. Farrar, B. L. Viviano, and R. D. Schreiber. 1994. Ligand-induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13: 1591-1600.
39. Pang, H., K. Miranda, and A. Fine. 1998. Sp3 regulates Fas expression in lung epithelial cells. Biochem. J. 333: 209-213.
40. Schmelz, K., T. Wieder, I. Tamm, A. Muller, F. Essmann, C. C. Geilen, K. Schulze-Osthoff, B. Dorken, and P. T. Daniel. 2004. Tumor necrosis factor α sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-κB. Oncogene 23: 6743-6759.
41. Xu, J., J. Y. Zhou, and G. S. Wu. 2006. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor α-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res. 66: 10092-10099.
42. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
43. Decker, T., P. Kovarik, and A. Meinke. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17: 121-134.
44. Eisenbeis, C. F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9: 1377-1387.
45. Meraro, D., S. Hashmueli, B. Koren, A. Azriel, A. Oumard, S. Kirchhoff, H. Hauser, S. Nagulapalli, M. L. Atchison, and B. Z. Levi. 1999. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163: 6468-6478.
46. Nagulapalli, S., and M. L. Atchison. 1998. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol. Cell. Biol. 18: 4639-4650.
47. Kanno, Y., C. A. Kozak, C. Schindler, P. H. Driggers, D. L. Ennist, S. L. Gleason, J. E. Darnell, Jr., and K. Ozato. 1993. The genomic structure of the murine ICSBP gene reveals the presence of the γ interferon-responsive element, to which an ISGF3 α subunit (or similar) molecule binds. Mol. Cell. Biol. 13: 3951-3963.
48. Bovolenta, C., P. H. Driggers, M. S. Marks, J. A. Medin, A. D. Politis, S. N. Vogel, D. E. Levy, K. Sakaguchi, E. Appella, J. E. Coligan, et al. 1994. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. USA 91: 5046-5050.
49. Dunn, G. P., K. C. Sheehan, L. J. Old, and R. D. Schreiber. 2005. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Res. 65: 3447-3453.
50. Contursi, C., I. M. Wang, L. Gabriele, M. Gadina, J. O'Shea, H. C. Morse, 3rd, and K. Ozato. 2000. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNγ-responsive promoters in macrophages. Proc. Natl. Acad. Sci. USA 97:91-96.
51. Smyth, M. J., G. P. Dunn, and R. D. Schreiber. 2006. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 90: 1-50.
52. Poehlein, C. H., H. M. Hu, J. Yamada, I. Assmann, W. G. Alvord, W. J. Urba, and B. A. Fox. 2003. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-γ double knockout effector T cells. J. Immunol. 170: 2004-2013.
53. Mamane, Y., C. Heylbroeck, P. Genin, M. Algarte, M. J. Servant, C. LePage, C. DeLuca, H. Kwon, R. Lin, and J. Hiscott. 1999. Interferon regulatory factors: the next generation. Gene 237: 1-14.
54. Sharf, R., A. Azriel, F. Lejbkowicz, S. S. Winograd, R. Ehrlich, and B. Z. Levi. 1995. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270: 13063-13069.
55. phox expression. J. Biol. Chem. 273: 13957-13965.
56. phox expression. J. Immunol. 163: 6095-6105.